Aims Rheumatoid arthritis is a chronic inflammatory condition that affects approximately 1%
of the world's population. There are a wide number of guidelines and recommendations …

Systemic lupus erythematosus (SLE) is a chronic, relapsing–remitting, multisystemic
autoimmune inflammatory disorder that predominantly affects women of childbearing age. Much …

Background Effective antiviral therapy is important for tackling the coronavirus disease 2019
(COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, …

Background The combination of cyclophosphamide and prednisolone is effective for the
treatment of severe lupus nephritis but has serious adverse effects. Whether mycophenolate …

Dendritic cells (DCs) constitute a heterogeneous population of professional antigen presenting
cells which are the initiators and key regulators for both immunity and tolerance induction…

Background Persistent use of glucocorticoid drugs is associated with bone loss and increased
fracture risk. Concurrent oral bisphosphonates increase bone mineral density and reduce …

Aims Treating to low disease activity is routine in rheumatoid arthritis, but no comparable
goal has been defined for systemic lupus erythematosus (SLE). We sought to define and …

Systemic lupus erythematosus is a complex and potentially fatal autoimmune disease,
characterized by autoantibody production and multi-organ damage. By a genome-wide …

Objective To determine the incidence of ovarian failure after cyclophosphamide (CYC)
treatment for systemic lupus erythematosus (SLE) and to identify the risk factors for this …

Systemic lupus erythematosus (SLE), a worldwide autoimmune disease with high heritability,
shows differences in prevalence, severity and age of onset among different ancestral …